![]() |
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Fusion gene ID: 29551 |
FusionGeneSummary for PTPRK_SPARCL1 |
![]() |
Fusion gene information | Fusion gene name: PTPRK_SPARCL1 | Fusion gene ID: 29551 | Hgene | Tgene | Gene symbol | PTPRK | SPARCL1 | Gene ID | 5796 | 8404 |
Gene name | protein tyrosine phosphatase, receptor type K | SPARC like 1 | |
Synonyms | R-PTP-kappa | MAST 9|MAST9|PIG33|SC1 | |
Cytomap | 6q22.33 | 4q22.1 | |
Type of gene | protein-coding | protein-coding | |
Description | receptor-type tyrosine-protein phosphatase kappadJ480J14.2.1 (protein tyrosine phosphatase, receptor type, K (R-PTP-KAPPA, protein tyrosine phosphatase kappa , protein tyrosine phosphatase kappaprotein-tyrosine phosphatase kappaprotein-tyrosine phospha | SPARC-like protein 1SPARC-like 1 (hevin)high endothelial venule proteinproliferation-inducing protein 33 | |
Modification date | 20180519 | 20180523 | |
UniProtAcc | Q15262 | Q14515 | |
Ensembl transtripts involved in fusion gene | ENST00000368226, ENST00000368227, ENST00000532331, ENST00000368213, ENST00000368210, ENST00000368215, ENST00000368207, ENST00000524481, ENST00000525459, | ENST00000282470, ENST00000418378, ENST00000503414, | |
Fusion gene scores | * DoF score | 26 X 12 X 13=4056 | 10 X 8 X 5=400 |
# samples | 34 | 11 | |
** MAII score | log2(34/4056*10)=-3.57645100086564 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | log2(11/400*10)=-1.86249647625006 possibly effective Gene in Pan-Cancer Fusion Genes (peGinPCFGs). DoF>8 and MAII<0 | |
Context | PubMed: PTPRK [Title/Abstract] AND SPARCL1 [Title/Abstract] AND fusion [Title/Abstract] | ||
Functional or gene categories assigned by FusionGDB annotation |
* DoF score (Degree of Frequency) = # partners X # break points X # cancer types ** MAII score (Major Active Isofusion Index) = log2(# samples/DoF score*10) |
![]() |
Partner | Gene | GO ID | GO term | PubMed ID |
Hgene | PTPRK | GO:0006470 | protein dephosphorylation | 16263724 |
Hgene | PTPRK | GO:0007165 | signal transduction | 16849327 |
Hgene | PTPRK | GO:0007179 | transforming growth factor beta receptor signaling pathway | 15899872 |
Hgene | PTPRK | GO:0008285 | negative regulation of cell proliferation | 15899872|18276111 |
Hgene | PTPRK | GO:0010839 | negative regulation of keratinocyte proliferation | 16263724 |
Hgene | PTPRK | GO:0030336 | negative regulation of cell migration | 18276111 |
Hgene | PTPRK | GO:0034394 | protein localization to cell surface | 18276111 |
Hgene | PTPRK | GO:0034614 | cellular response to reactive oxygen species | 16849327 |
Hgene | PTPRK | GO:0034644 | cellular response to UV | 16849327 |
Hgene | PTPRK | GO:0045786 | negative regulation of cell cycle | 15899872 |
Hgene | PTPRK | GO:0045892 | negative regulation of transcription, DNA-templated | 18276111 |
![]() (ChiTars (NAR, 2018), tumorfusions (NAR, 2018), Gao et al. (Cell, 2018)) * All genome coordinats were lifted-over on hg19. * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
Data type | Source | Cancer type | Sample | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
TCGA | RV | BRCA | TCGA-A2-A0CY-01A | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
* LD: Li Ding group's fusion gene list RV: Roel Verhaak group's fusion gene list ChiTaRs fusion database |
![]() * Click on the break point to see the gene structure around the break point region using the UCSC Genome Browser. |
ORF | Henst | Tenst | Hgene | Hchr | Hbp | Hstrand | Tgene | Tchr | Tbp | Tstrand |
5CDS-5UTR | ENST00000368226 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368226 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368226 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368227 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368227 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368227 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000532331 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000532331 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000532331 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368213 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368213 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368213 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368210 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368210 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368210 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368215 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368215 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368215 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368207 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368207 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5CDS-5UTR | ENST00000368207 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5UTR-5UTR | ENST00000524481 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5UTR-5UTR | ENST00000524481 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
5UTR-5UTR | ENST00000524481 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
intron-5UTR | ENST00000525459 | ENST00000282470 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
intron-5UTR | ENST00000525459 | ENST00000418378 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
intron-5UTR | ENST00000525459 | ENST00000503414 | PTPRK | chr6 | 128505577 | - | SPARCL1 | chr4 | 88420737 | - |
Top |
FusionProtFeatures for PTPRK_SPARCL1 |
![]() |
Hgene | Tgene |
PTPRK | SPARCL1 |
Regulation of processes involving cell contact andadhesion such as growth control, tumor invasion, and metastasis.Negative regulator of EGFR signaling pathway. Forms complexes withbeta-catenin and gamma-catenin/plakoglobin. Beta-catenin may be asubstrate for the catalytic activity of PTPRK/PTP-kappa.{ECO:0000269|PubMed:19836242}. |
![]() * Minus value of BPloci means that the break pointn is located before the CDS. |
- In-frame and retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
- In-frame and not-retained protein feature among the 13 regional features. |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Protein feature | Protein feature note |
Top |
FusionGeneSequence for PTPRK_SPARCL1 |
![]() (nt: nucleotides, aa: amino acids) |
* Fusion amino acid sequences. |
* Fusion transcript sequences (only coding sequence (CDS) region). |
* Fusion transcript sequences (Full-length transcript). |
Top |
FusionGenePPI for PTPRK_SPARCL1 |
![]() |
![]() |
Hgene | Hgene's interactors | Tgene | Tgene's interactors |
PTPRK | PSMD11, TK1, CTNNB1, JUP, CSNK2B, FKBP8, GADD45G, GADD45A, LGALS3, LGALS8, LGALS9, LAMB2, ATRN, CACNA2D2, ECE1, CES3, TCTN2, LRP1B, INSR, PXDN, FRAS1, CACNA2D1, LAMA5, CD109, POGLUT1, ARSK, MEGF8, UBR3, ARSA, GALNS, ARSG, LAMB1, LRIG3, LRIG1, B3GALTL, SCARB1, ADAM9, NPC1, SUSD1, COL6A2, EOGT, PLXNA2, PLXNA3, PLXNA1, EGFR, MOXD1, CCDC102A, CHST10, COL6A1, DNAJB9, MAN2A1, CNTNAP3, PLXNB2, MANBA, ITGA8, MGRN1, ARSB, COL4A2, TMEM67, FBLN1, CLN5, SCARB2, FUT11, GLG1, CERCAM, ERO1LB, DCBLD2, CHST12, AMIGO1, PCSK5, LAMA3, SIAE, GNPTG, CTSF, PLAT, BCHE, ITGA4, GALNT18, MICA, LEPREL2, WNT5A, DGCR2, MAN2A2, BTD, SP3, AMIGO3, ANKRD46, HYAL2, TMEM132A, RIPK3, ATP2A2, SIPA1L3, ARHGAP32, TANC1, MINK1, PKP4, NCKAP5L, PEAK1, PIK3R1, SEC24B, RPL28, PTPRU, DEFA5, PCDHGB1, TUFM, MMP26, NID2, PCDHGB4, LYPD1, ZNF3, TMPRSS11B, BMP7 | SPARCL1 | EGFR, DISC1, SKIL |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Still interaction with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
![]() |
Partner | Gene | Hbp | Tbp | ENST | Strand | BPexon | TotalExon | Protein feature loci | *BPloci | TotalLen | Interaction lost with |
Top |
RelatedDrugs for PTPRK_SPARCL1 |
![]() (DrugBank Version 5.1.0 2018-04-02) |
Partner | Gene | UniProtAcc | DrugBank ID | Drug name | Drug activity | Drug type | Drug status |
Top |
RelatedDiseases for PTPRK_SPARCL1 |
![]() (DisGeNet 4.0) |
Partner | Gene | Disease ID | Disease name | # pubmeds | Source |
Hgene | PTPRK | C0025202 | melanoma | 2 | CTD_human |
Hgene | PTPRK | C0033578 | Prostatic Neoplasms | 1 | CTD_human |
Tgene | SPARCL1 | C0014175 | Endometriosis | 1 | CTD_human |
Tgene | SPARCL1 | C0014544 | Epilepsy | 1 | CTD_human |